Dermatology Medical News about deoxycholate

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

New Vaccine Approved for Cervical Cancer

Roberta Buell, MBA
HHS Weighs In On Health Reform

Dorothy J. Schirf, MD

Technology Advances

Strategic Therapy of Glioblastoma Gains Ground

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment
Mycoses, 10/29/09

Goldani LZ et al. – The combination of amphotericin B and sodium deoxycholate is the formulation most used in clinical practice. The development of new agents such as amphotericin with lipid formulations, caspofungin, voriconazole and other azolic derivatives, promoted alternatives to amphotericin B deoxycholate. However, because of the high cost of these new drugs, their use is difficult in a scenario of limited resources.

<< Previous
Variations of skin biophysical properties after recreational...

Next >>
Biliary drainage, photodynamic therapy and chemotherapy for...